|
CMMB Chemomab Therapeutics Ltd 1534248 |
| Income Statement |
|
Net Income
|
zk2532798
|
-3,631,000 |
| Balance Sheet |
|
Current Assets
|
13,455,000 |
|
Assets
|
14,544,000 |
|
Current Liabilities
|
4,308,000 |
|
Liabilities
|
4,559,000 |
|
Equity
|
9,985,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-7,191,000 |
|
Investing Cash Flow
|
2,801,000 |
| Market Analysis |
|
Price
|
1.35 |
|
BVPS
|
0.01 |
|
PB
|
178.38 |
|
PS
|
4.49 |
|
FCF
|
-4,390,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CMMB documents filed with the SEC.
CMMB Filings
Clear
